Stock listing
Prism Biolab Co. Ltd
Selected listing: 206A · TSE · JPY · JP
Prism Biolab Co. Ltd (Tokyo:206A), Health Technology. Latest release Aug 14, 2026: [Summary] Non-consolidated Financial Results for the Nine Months…
- Ticker
- Tokyo:206A
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tokyo
- Currency
- JPY
About Prism Biolab Co. Ltd
The company focuses on biolab solutions and innovations. Investors can find relevant information about its operations and market performance on its dedicated public company page.
Latest news from Prism Biolab Co. Ltd
[Summary] Non-consolidated Financial Results for the Nine Months of the Fiscal Year Ending September 30, 2026 (Under Japanese GAAP)
August 14, 2026
PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement
March 11, 2026
PRISM BioLab and Talus Bioscience Join Forces to Discover Novel Inhibitors of Transcription Factor and Protein-Protein Interaction Targets
December 17, 2025
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.
November 14, 2025
Research Prism Biolab Co. Ltd
Prism Biolab Co. Ltd company profile
View the public company page for Prism Biolab Co. Ltd on 6ix.
Prism Biolab Co. Ltd news
Read company news and market updates connected to Prism Biolab Co. Ltd.
Prism Biolab Co. Ltd investor events
Find investor webinars, events, and replay context for Prism Biolab Co. Ltd.